Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02463630
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.7 |  |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7G | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2HTU | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2F10 | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7H | 0.71 | |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7F | 0.71 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.78 | |
OLN | (S)-2-ACETAMIDO-5-UREIDOPENTANOIC ACID | A | 1YH1 | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.71 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.71 | |
ARO | C-GAMMA-HYDROXY ARGININE | A,B,C,D,E,F | 1FFV | 0.72 | |
| ARO | C-GAMMA-HYDROXY ARGININE | A,B,C,D,E,F | 1FFU | 0.72 | |
C99 | {(2R)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]- 2-HYDROXY-4,5-DIOXOIMIDAZOLIDIN- 1-YL}ACETIC ACID | A | 2HCG | 0.71 | |
EP2 | methyl N-[(2S)-4-{[(1S)-1-{[(2S)- 2-carboxypyrrolidin-1-yl]carbonyl}- 3-methylbutyl]amino}-2-hydroxy- 4-oxobutanoyl]-L-leucylglycylglycinate | B | 1SP4 | 0.74 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.7 | |
SUG | N~2~-(3-CARBOXYPROPANOYL)-L-ARGININE | A,B,C,D | 1YNI | 0.74 | |
| SUG | N~2~-(3-CARBOXYPROPANOYL)-L-ARGININE | A | 2P8C | 0.74 | |
GNA | 2,4-DEOXY-4-GUANIDINO-5-N-ACETYL- NEURAMINIC ACID | A | 2QWE | 0.7 | |
MGG | 2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO- PENTANOIC ACID | A | 1CVQ | 0.79 | |
PCX | DEOXYGUANIDINOPROCLAVAMINIC ACID | A | 1GVG | 0.74 | |
| PCX | DEOXYGUANIDINOPROCLAVAMINIC ACID | A,B | 1MC1 | 0.74 | |
AAG | N-ALPHA-L-ACETYL-ARGININE | A | 1DRY | 0.77 | |
CMA | N2-(CARBOXYETHYL)-L-ARGININE | A,B | 1JGT | 0.73 | |
2NC | N-{(2S)-2-[(N-acetyl-L-threonyl- L-isoleucyl)amino]hexyl}-L-norleucyl- L-glutaminyl-L-argininamide | A,B | 3BVA | 0.8 | |
SJ1 | N-(ISOBUTOXYCARBONYL)-D-SERYL-N- ((1S)-4-{[AMINO(IMINO)METHYL]AMINO}- 1-FORMYLBUTYL)-L-ALANINAMIDE | U | 1W10 | 0.78 | |
D20 | N~5~-{IMINO[(2-METHOXYETHYL)AMINO]METHYL}- L-ORNITHINE | A,B | 2JAJ | 0.7 | |
169 | 1-(4-TERT-BUTYLCARBAMOYL-PIPERAZINE- 1-CARBONYL)-3-(3-GUANIDINO-PROPYL)- 4-OXO-AZETIDINE-2-CARBOXYLIC ACID | A | 1RXP | 0.72 | |
E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1AEC | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 2PRE | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1CV8 | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 3C9E | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B | 3BCN | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1ATK | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 3BPF | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1TLO | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1QX6 | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A | 1MEG | 0.75 | |
| E64 | N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- BUTYL]-GUANIDINE | A,B,C,D | 2BDZ | 0.75 | |